News

Filter

Current filters:

None

82 to 91 of 97852 results

NICE gives green light to Bayer’s Eylea for DME

20-02-2015

In a preliminary recommendation issued today, England’s health costs watchdog the National Institute…

BayerEyleaOphthalmicsPharmaceuticalPricingRegulationUK

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

20-02-2015

The UK’s National Institutes of Health and Care Excellence has recommended Ozurdex (dexamethasone),…

AllerganDexamethasoneOphthalmicsOzurdexPharmaceuticalRegulationUK

Move of Bayer’s Olivier Brandicourt to become Sanofi CEO confirmed

Move of Bayer’s Olivier Brandicourt to become Sanofi CEO confirmed

20-02-2015

Confirming what the media had been saying most of the week, French pharma major Sanofi late yesterday…

BayerBoardroomManagementPharmaceuticalSanofi

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

20-02-2015

Japanese drug major Astellas has published results of a study demonstrating that early and sustained…

AdvagrafAstellasNephrology and HepatologyPharmaceuticalResearch

NewLink earns $20 million Ebola vaccine milestone from Merck

19-02-2015

US biotech firm NewLink Genetics says it had received notification from pharma giant Merck & Co that…

BiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesVaccines

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

Hospira’s biosimilar Inflectra comparable to Remicade in IBD treatment

19-02-2015

Positive data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first…

BiosimilarsBiotechnologyGastro-intestinalsHospiraInflectraJohnson & JohnsonMerck & CoRemicadeResearch

Genmab inks DuoBody deal with BioNovion in the field of immuno-oncology

19-02-2015

Danish biotech company Genmab has entered into a co-development and commercialization agreement with…

BioNovionBiotechnologyDuoBodyGenmabImmunologicalsLicensingOncologyResearch

Kymab appoints Anne Hyland as chief financial officer

Kymab appoints Anne Hyland as chief financial officer

19-02-2015

Kymab, a pharma company based in Cambridge, UK, focusing on monoclonal antibodies, has appointed Anne…

BiotechnologyBoardroomKymabPharmaceuticalUK

NICE sets too high a QALY cost for NHS drugs, new research claims

NICE sets too high a QALY cost for NHS drugs, new research claims

19-02-2015

The price the National Heath Service in England agrees to pay for new medicines is too high, causing…

HealthcarePharmaceuticalPricingUK

82 to 91 of 97852 results

COMPANY SPOTLIGHT

Menarini

Back to top